In solid tumors, neoadjuvant or adjuvant immune checkpoint blockade increases treatment-related grade 3 or 4 adverse events.


Journal

Annals of internal medicine
ISSN: 1539-3704
Titre abrégé: Ann Intern Med
Pays: United States
ID NLM: 0372351

Informations de publication

Date de publication:
02 Apr 2024
Historique:
medline: 1 4 2024
pubmed: 1 4 2024
entrez: 1 4 2024
Statut: aheadofprint

Résumé

Fujiwara Y, Horita N, Adib E, et al.

Identifiants

pubmed: 38560904
doi: 10.7326/J24-0013
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Auteurs

Luca Bertolaccini (L)

IEO, European Institute of Oncology IRCCS, Milan, Italy (L.B.).

Classifications MeSH